We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gottlieb Flags New Approaches to Opioids, Drug Pricing, Internal Challenges
Gottlieb Flags New Approaches to Opioids, Drug Pricing, Internal Challenges
FDA Commissioner Scott Gottlieb offered an update on the agency’s plans to address the opioid epidemic, encourage market competition, and tackle internal agency issues, in remarks Tuesday to the Alliance for a Stronger FDA in Washington, D.C.